Logo image of MGCD

Mgc Diagnostics Corp. (MGCD) Stock Price, Quote, News and Overview

NASDAQ:MGCD - Nasdaq -

11.03  0 (0%)

MGCD Quote, Performance and Key Statistics

Mgc Diagnostics Corp.

NASDAQ:MGCD (12/28/2017, 8:10:00 PM)

11.03

0 (0%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High11.2
52 Week Low6.24
Market Cap48.64M
Shares4.41M
FloatN/A
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


MGCD short term performance overview.The bars show the price performance of MGCD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

MGCD long term performance overview.The bars show the price performance of MGCD in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of MGCD is 11.03 null. In the past month the price increased by 0.64%. In the past year, price increased by 39.8%.

Mgc Diagnostics Corp. / MGCD Daily stock chart

About MGCD

Company Profile

MGC Diagnostics Corporation is a medical technology company dedicated to Cardio-Respiratory health solutions. It develops, manufactures and markets non-invasive diagnostic systems. The Company serves hospitals, university-based medical centers, medical clinics, physician offices, health and fitness clubs, weight loss clinics, and personal training studios. MGC Diagnostics Corporation, formerly known as Angeion Corporation, is based in Saint Paul, Minnesota.

Company Info

Mgc Diagnostics Corp.

350 OAK GROVE PARKWAY

ST PAUL MN 55127

CEO: Todd M. Austin

Phone: 651-484-4874

Mgc Diagnostics Corp. / MGCD FAQ

What is the stock price of Mgc Diagnostics Corp. today?

The current stock price of MGCD is 11.03 null.


What is the ticker symbol for Mgc Diagnostics Corp. stock?

The exchange symbol of Mgc Diagnostics Corp. is MGCD and it is listed on the Nasdaq exchange.


On which exchange is MGCD stock listed?

MGCD stock is listed on the Nasdaq exchange.


What is Mgc Diagnostics Corp. worth?

Mgc Diagnostics Corp. (MGCD) has a market capitalization of 48.64M null. This makes MGCD a Nano Cap stock.


What are the support and resistance levels for Mgc Diagnostics Corp. (MGCD) stock?

Mgc Diagnostics Corp. (MGCD) has a support level at 11 and a resistance level at 11.04. Check the full technical report for a detailed analysis of MGCD support and resistance levels.


Should I buy Mgc Diagnostics Corp. (MGCD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Mgc Diagnostics Corp. (MGCD) stock pay dividends?

MGCD does not pay a dividend.


What is the Price/Earnings (PE) ratio of Mgc Diagnostics Corp. (MGCD)?

Mgc Diagnostics Corp. (MGCD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.83).


MGCD Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to MGCD. When comparing the yearly performance of all stocks, MGCD is one of the better performing stocks in the market, outperforming 88.69% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MGCD Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to MGCD. MGCD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MGCD Financial Highlights

Over the last trailing twelve months MGCD reported a non-GAAP Earnings per Share(EPS) of -0.8346. The EPS decreased by -367.93% compared to the year before.


Industry RankSector Rank
PM (TTM) -8.85%
ROA -12.72%
ROE -24.57%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%185.81%
Sales Q2Q%5.55%
EPS 1Y (TTM)-367.93%
Revenue 1Y (TTM)3.5%

MGCD Ownership and Analysts


Ownership
Inst Owners23.29%
Ins Owners1.51%
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y-100%
Revenue Next YearN/A